Stay updated with breaking news from Weight loss new. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with Bimagrumab safe for patients with obesity, diabetes Bimagrumab is an antibody that blocks activ in type II receptors and stimulates skeletal muscle growth Thursday January 14, 2021 12:14 PM, IANS New York: Researchers have found that treatment with Bimagrumab is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and Type-2 diabetes. Bimagrumab is an antibody that blocks activ in type II receptors and stimulates skeletal muscle growth. "These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits," said researcher Steve Heymsfield from Pennington Biomedical Research Center, in the US.